Immunolocalization of corticotropin-releasing hormone (CRH) and its receptors (CRHR1 and CRHR2) in human endometrial carcinoma: CRHR1 as a potent prognostic factor.

Int J Gynecol Cancer · 2014 · PMC4215916 · PMID 25254562

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

P < 0.05 was considered significant, and P ≥ 0.05 but P < 0.10 was considered borderline significant, and these values were subjected to multivariate analysis. 21 Statistical analysis was performed using JMP Pro version 9.02 (SAS Institute, Inc, Cary, NC).

also in 11,409 other papers

marginally significantno p-value reported

The results of univariate analysis of disease-free survival by Cox model indicated PR status ( P = 0.001) and CRHR1 status ( P = 0.023) as significant prognostic factors for disease-free survival and stage ( P = 0.057) and lymph node metastasis ( P = 0.096) as marginally significant prognostic factors (Table 4 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.